Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Log in | Channel Management
Novartis News Via Stat: Latest on the Pharmaceutical Company
Novartis 2025: Strengthening foundations and delivering returns ...
Novartis Oncology Logo
Novartis AG $NVS Shares Sold by WealthTrust Axiom LLC
The Novartis Logo History, Colors, Font, And Meaning
Novartis announces new organizational structure
Novartis Loses Over $2.7 Billion In Patent Appeal Of Multiple Sclerosis ...
Novartis Logo Transparent
Novartis - Wikipedia
Novartis says Phase 3 data prove new antimalarial could address resistance
Novartis
Novartis logo on the Banting 1 building, Novartis Campus Basel ...
Novartis plans NC manufacturing hub as part of $23bn US investment
Project : Novartis - Big Image Group Pte Ltd
Novartis India shares surge most in over six years on this important ...
Swiss pharmaceutical giant Novartis to open $1.1 billion global ...
Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in ...
Advanced Accelerator Applications A Novartis Company
Novartis pays $12B for late-stage dystrophy biotech Avidity
Your Novartis Benefits & Career: Financial Planning for Employees and ...
Será que todo mundo terá acesso aos medicamentos da Novartis? - SWI ...
Novartis wins approval for first US biosimilar drug | Fox News
Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful ...
Novartis Pharmaceuticals
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Novartis: News, Hintergründe und Analysen
Novartis Heart Failure Medicine Entresto Wins EU Approval
Harnessing design thinking to increase access to healthcare
Novartis: contratación directa para Kisqali y más - Pharmabiz.NET
Novartis to cut over 2000 jobs | Business | Chemistry World
Novartis: Últimas noticias económicas de Novartis
Novartis – Wikipedia
Novartis streicht Funktion des Schweizer Länderpräsidenten | Nau.ch
Novartis’s big bet on sickle cell disease struggles to reach Kenya ...
Novartis unveils new hybrid office as part of its Malaysian footprint ...
Novartis plans to spin off generics division Sandoz - SWI swissinfo.ch
Cosentyx Becomes First Novartis Medicine Offered at 55% Discount ...
Novartis will US-Unternehmen Medicines kaufen | Nau.ch
Novartis Looks to Buy French Firm to Bolster Cancer Portfolio - The New ...
Novartis odčlenil divíziu generických liečiv Sandoz a uviedol ju na ...
Novartis transformation into a pure-play Innovative Medicines company ...
Novartis signs gene therapy deal with Voyager for $100 mln upfront and ...
Novartis Products
Novartis Wins U.S. OK for Biosimilar Version of Amgen's Enbrel - Drug ...
Novartis Vanrafia Phase III data support slowing of kidney function ...
Novartis: Aktuelle Entwicklungen im Überblick | Nau.ch
Contáctenos | Novartis Argentina S.A.
Novartis Logo High Resolution
Novartis’ Chinook-originated kidney disease drug gets accelerated approval
Novartis Earnings: Full-Year Guidance Increased to Reflect Avidity ...
Novartis Top 10 Products at Jeremy Sanchez blog
Novartis kommt 2027er-Profitabilitätsziel immer näher
Pharma giant Novartis to cut up to 400 jobs from Dublin site
FDA gives the go-ahead to restart Elevidys shipments | pharmaphorum
Novartis Announces Plans to Cut 400 Jobs in Dublin
Novartis Has Stockpiles to Withstand Potential Trump Tariffs, CEO Says
Novartis to license cancer drug to low- and middle-income countries
Who Got the Work?℠: Novartis Patent Fight, think! Protein Bar Class ...
Novartis says no sensitive data was compromised in cyberattack
Novartis Receives FDA Approval for Itvisma®, the only gene replacement ...
Novartis International Reports Double-Digit Growth in Core Operating ...
Novartis: Streamlining Analytics & AI Across the Organization | Dataiku
'Reimagined' Novartis Grows 5% in 2018
Novartis Geschäftsgeschichte , Geschichte – LNJE
Novartis to begin manufacturing prostate cancer treatment Pluvicto at ...
Novartis Lifts Full-Year Forecast Amid Strong Performances from Kisqali ...
At $2.1M, Novartis gene therapy will be world’s most expensive drug
Novartis confidently breaks out mid-stage data on Xolair competitor
Novartis drug combo shows promise in childhood brain cancer | Reuters
Novartis invierte 77,4 millones en sus fábricas en España
Novartis’ ianalumab shows promise in phase 3 Sjögren’s syndrome studies ...
Strategy Study: How Novartis Became a Multinational Pharmaceutical Giant
Novartis CEO criticizes US, EU efforts to curb drug company power - AOL
Novartis AG Receives First Ever FDA Approval for CAR-T
FDA Approves Novartis’s Heart Failure Drug - WSJ
Novartis halts US production for cancer drugs Lutathera, Pluvicto
Novartis отделя Sandoz - Economy.bg
Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump
Novartis Headquarters Uk
Novartis - BMAC - Biopharmaceutical Manufacturer's Advisory Council
Novartis ends development of KRAS drug, citing 'increasing options ...
Novartis übernimmt Tourmaline Bio für 1,4 Milliarden Dollar
Novartis: «Ήταν ένα δημιούργημα για να καταστραφεί ο Γιάννης Στουρνάρας ...
Novartis Strategy & Growth Update - YouTube
Novartis-Kandidat Iptacopan erreicht in Phase-III-Studie Ziele bei PNH ...
Novartis приобретает разработчика в области нейробиологии - Cadent ...
Novartis: Ενοχή των δύο πρώην προστατευόμενων μαρτύρων, αποφάσισε το ...
Novartis to acquire Avidity Biosciences for USD 12 billion
Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio ...
Novartis Stock Pops — As Travere Therapeutics Slides — On FDA Approval ...
Παγκόσμια Ημέρα Υγείας: Η δέσμευση της Novartis για ισότιμη πρόσβαση ...
Novartis Names Sandoz Board Members Ahead of Spin-Off
Novartis Home
Laboratoire Novartis Logo
Novartis soignes les malades , soulage les douleurs et améliore la vie ...
Novartis: Reimagining Medicine - Institute of Management & Strategy ...
Generate PMS data to assess patient safety : CDSCO Panel Tells Novartis ...
Novartis blames animal rights activists for attack on grave
Novartis Initiates Study Evaluating Impact of Higher Dosing of Cosentyx ...
Novartis CYStem Stem Cell and Gene Therapy Trial Is Moving Forward and ...
Novartis loses Indian patent fight in landmark ruling | Inquirer News
CONTENIDO INFORMÁTICO: Novartis
Novartis sickle-cell drug gets US FDA approval - Business & Finance ...
Υπόθεση Novartis
Novartis 'not leaving any stone unturned' for Kesimpta, Leqvio as ...
Καταπέλτης η εισαγγελέας στη δίκη Novartis, πρότεινε ενοχή Μαραγγέλη ...
Novartis Plans $3.9B Acquisition Of Advanced Accelerator Applications ...
Novartis Projects | Photos, videos, logos, illustrations and branding ...
Novartis banks EC approval for Enerzair Breezhaler - PharmaTimes
:max_bytes(150000):strip_icc()/GettyImages-458951947-29e3572b4d094cabbdc1e8eeb0074b9a.jpg)
